The US Supreme Court rules to preserve access to abortion pill mifepristone

Washington News ニュース

 The US Supreme Court rules to preserve access to abortion pill mifepristone
HealthBusinessU.S. News
  • 📰 KPRC2
  • ⏱ Reading Time:
  • 68 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 40%
  • Publisher: 68%

The U.S. Supreme Court has ruled unanimously to preserve access to the abortion pill mifepristone, a pill used in the most common way to end a pregnancy.

‘Covered in her brother’s blood’: Mom speaks on teen drunk driving after her 2 kids were involved in deadly DUI wreckCopyright 2024 Associated Press. All rights reservedto preserve access to the abortion pill mifepristone, a pill used in the most common way to end a pregnancy. The medication was used in nearlyopponents lacked the legal right to sue over the federal Food and Drug Administration’s approval of the medication, mifepristone, and the FDA’s subsequent actions to ease access to it.

The doctors also had to be capable of performing emergency surgery to stop excess bleeding and an abortion procedure if the drug didn’t end the pregnancy. Over the years, the FDA reaffirmed mifepristone’s safety and repeatedly eased restrictions, culminating in a 2021 decision doing away with any in-person requirements and allowing the pill to be sent through the mail.Nancy Northup, president and CEO of the Center for Reproductive Rights, expressed relief at Thursday's decision by the U.S.

Mini Timmaraju, president and CEO of the national abortion rights group Reproductive Freedom for All, echoed similar feelings. While expressing relief she also said, “This baseless push to block abortion access should never have been heard by them in the first place.”The mifepristone case began five months after the Supreme Court overturned Roe v. Wade. Abortion opponents initially won a sweeping ruling nearly a year ago fromThe 5th U.S.

U.S. President Joe Biden’s administration and drug manufacturers had warned that siding with abortion opponents in the case could undermine the FDA’s drug approval process beyond the abortion context by inviting judges to second-guess the agency’s scientific judgments. The Democratic administration and New York-based Danco Laboratories, which makes mifepristone, argued that the

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

KPRC2 /  🏆 80. in US

Health Business U.S. News

日本 最新ニュース, 日本 見出し

Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。

Supreme Court sends dispute over Arkansas' GOP-drawn congressional map back to lower courtSupreme Court sends dispute over Arkansas' GOP-drawn congressional map back to lower courtLawrence Hurley covers the Supreme Court for NBC News.
続きを読む »

NY court upholds mandatory abortion coverage; Albany diocese plans Supreme Court appealNY court upholds mandatory abortion coverage; Albany diocese plans Supreme Court appealALBANY, N.Y. (AP) New York can continue to require companies with health insurance plans to cover medically necessary abortions, the state's highest court rule
続きを読む »

Supreme Court unanimously strikes down legal challenge to abortion pill mifepristoneSupreme Court unanimously strikes down legal challenge to abortion pill mifepristoneThe ruling preserves access to the mail-order medication nationwide.
続きを読む »

Supreme Court Upholds Access to Abortion Pill in Unanimous VoteSupreme Court Upholds Access to Abortion Pill in Unanimous VoteThe biggest battle over abortion rights since Roe v. Wade is over for now—and the Supreme Court has averted a major crisis for reproductive healthcare.
続きを読む »

Supreme Court Protects Access to Abortion Pill in Surprise RulingSupreme Court Protects Access to Abortion Pill in Surprise RulingThe U.S. Supreme Court unanimously ruled on Thursday, June 13, that it won't restrict access to abortion pill mifepristone.
続きを読む »

Supreme Court Upholds Access to Abortion PillSupreme Court Upholds Access to Abortion PillThe Supreme Court threw out a legal challenge to mifepristone, preserving access to the widely used abortion medication.
続きを読む »



Render Time: 2025-04-28 08:10:27